COMMUNIQUÉS West-GlobeNewswire

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 novembre 2024
11/12/2024
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 novembre 2024 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, [...]
AB Science will host a live webcast on Monday December 16, 2024, from 5.30pm to 6.30pm CET
11/12/2024
PRESS RELEASE AB SCIENCE WILL HOST A LIVE WEBCAST ON MONDAY DECEMBER 16, 2024 FROM 5.30PM TO 6.30PM CET Paris, 11 December, 2024, 6pm CET AB Science SA (Euronext – FR0010557264 – AB) will host a live webcast on Monday [...]
AB Science tiendra une conférence virtuelle le lundi 16 décembre 2024, de 17h30 à 18h30
11/12/2024
COMMUNIQUE DE PRESSE AB SCIENCE TIENDRA UNE CONFERENCE VIRTUELLE LE LUNDI 16 DECEMBRE 2024, DE 17H30 A 18H30 Paris, 11 décembre 2024, 18h AB Science SA (Euronext – FR0010557264 – AB) tiendra une conférence virtuelle le [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2024
11/12/2024
Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2024 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 30 novembre 2024
11/12/2024
Nombre total de droits de vote et d’actions composant le capital social au 30 novembre 2024 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary Cancer Vaccine Tedopi®
11/12/2024
OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary Cancer Vaccine Tedopi® ARTEMIA: Clinical trial protocol approved globally. Most countries and sites activated, with full activation [...]
OSE Immunotherapeutics annonce des avancées cliniques positives de Tedopi®, son vaccin thérapeutique contre le cancer en développement avancé
11/12/2024
OSE Immunotherapeutics annonce des avancées cliniques positives de Tedopi®, son vaccin thérapeutique contre le cancer en développement avancé ARTEMIA : Protocole de l’essai clinique approuvé au niveau mondial. Une [...]
TECVAYLI®▼ (téclistamab) révèle son potentiel en tant que traitement combiné de première ligne destiné aux patients atteints d’un myélome multiple nouvellement diagnostiqué
11/12/2024
100 pour cent des patients chez qui la maladie résiduelle minimale (MRM) était évaluable ont atteint une MRM négative dans le cadre de l’étude MajesTEC-5 évaluant le produit en traitement d’induction, et dans le cadre [...]
RapidPulse Receives FDA Approval to Begin IDE Study in Ischemic Stroke Using Innovative Cyclic Aspiration System – Recently Completed Clinical Trial Shows Significantly Higher First Pass and Frontline Success Rates
11/12/2024
MIAMI, Dec. 11, 2024 (GLOBE NEWSWIRE) -- RapidPulse, Inc., a Delaware corporation headquartered in Miami, Florida focused on improving the treatment success rate for acute ischemic stroke (AIS) announced that the United [...]
SABCS 2024: New Research Assesses iCAD’s Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations
11/12/2024
Reveals Higher Prevalence of Breast Arterial Calcifications (BAC) in Breast Cancer Patients, Suggesting Potential Need for Cardiovascular Assessment Alongside Oncological Treatment NASHUA, N.H., Dec. 11, 2024 (GLOBE [...]
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
11/12/2024
Please see enclosed pdf. Attachment 11122024_trading_in_shares_GL
USOSM President and CEO Richard Hall Named to SCALE’s Most Influential Healthcare Leaders List
11/12/2024
IRVING, Texas, Dec. 11, 2024 (GLOBE NEWSWIRE) -- For the second year in a row, SCALE Healthcare has named U.S. Oral Surgery Management ( USOSM ) President and CEO Richard Hall to its list of Most Influential Healthcare [...]
NADP Report Reveals Overall Decrease in Dental Benefits Enrollment
11/12/2024
Some Market Growth Seen in Public and Private Segments DALLAS, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Enrollment in dental benefits decreased last year to 87% of the U.S. population— a 1% decline from the previous year, [...]
Phenocell and Amarna Therapeutics Awarded Eurostars Grant to Assess a Gene Therapy for Dry AMD using a novel 3-dimensional iPSC-derived Retinal Model of the Disease
11/12/2024
Grasse, France and Leiden, the Netherlands – 11 December 2024 – Phenocell SAS (part of Axol Bioscience ) a leading provider of stem cell-derived models and services, and Amarna Therapeutics , a biotechnology pioneer in [...]
New Clinical Trial of eTNS for Pediatric ADHD to Commence at Denmark’s Center for Evidence-Based Psychiatry
11/12/2024
LOS ANGELES, Dec. 11, 2024 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. , a Los Angeles-based bioelectronics company, announced today that the Center for Evidence-Based Psychiatry (CEBP) in Denmark has approved commencing [...]
Provectus Biopharmaceuticals Launches VisiRose, Provectus’s Founded Entity for Pharmaceutical-grade Rose Bengal Sodium-based Treatments in Ophthalmology
11/12/2024
KNOXVILLE, Tenn., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) announced today the launch of VisiRose, Inc. (“VisiRose”), Provectus’s first Founded [...]
60 Degrees Pharmaceuticals Expands Tafenoquine Clinical Trial for Babesiosis to Brigham and Women’s Hospital
11/12/2024
The trial (NCT06207370) evaluates tafenoquine combined with standard treatment for babesiosis, addressing a critical unmet medical need. The clinical site is led by Brigham and Women’s Hospital researchers Ann Woolley, [...]
Gain Therapeutics To Present At Biotech Showcase 2025
11/12/2024
Presentation to Feature Lead Drug Candidate GT-02287 and Magellan Drug Discovery Platform BETHESDA, Md., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical- [...]
Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare Conference
11/12/2024
The overview presentation will review some of the Company’s recent achievements as well as the outlook for upcoming data milestones JERUSALEM, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (“Alpha Tau”, or [...]

Pages